Cancer Policy NIH employee placed on leave after openly criticizing Trump November 21, 2025Vol.51 No.43By Claire Marie Porter
Cancer Policy Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer November 21, 2025Vol.51 No.43By Claire Marie Porter and Jacquelyn Cobb
Cancer Policy Makary, Prasad describe FDA’s new “plausible mechanism pathway” to get bespoke therapies to market sans RCT November 21, 2025Vol.51 No.43By Jacquelyn Cobb
Cancer Policy Trump signs CR that funds government through Jan. 30, ending the longest shutdown in U.S. history November 14, 2025Vol.51 No.42By Jacquelyn Cobb
Cancer Policy Trump administration and Cornell reach agreement to restore federal research funding November 14, 2025Vol.51 No.42By Jacquelyn Cobb and Claire Marie Porter
Cancer Policy CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices November 14, 2025Vol.51 No.42By Sara Willa Ernst and Jacquelyn Cobb
Cancer Policy HHS (again) postpones USPSTF meeting November 07, 2025Vol.51 No.41By Claire Marie Porter
Cancer Policy Zongertinib, dostarlimab chosen in second batch of National Priority Vouchers recipients November 07, 2025Vol.51 No.41By Jacquelyn Cobb
Cancer Policy American Academy of Pediatrics: Leucovorin is not recommended for routine use in autistic children November 07, 2025Vol.51 No.41By Sara Willa Ernst
Cancer Policy White House makes deal with Eli Lilly, Novo Nordisk to lower weight loss drug prices and begin Medicare coverage November 07, 2025Vol.51 No.41By Jacquelyn Cobb
